NCT04196959View on ClinicalTrials.gov

Evaluation of TYR Sphere

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

August 1, 2020

Study Completion Date

August 1, 2020

Conditions
TyrosinemiasAlkaptonuriaTyrosinemia, Type ITyrosinemia, Type IITyrosinemia, Type III
Interventions
DIETARY_SUPPLEMENT

TYR sphere

TYR sphere is a powdered protein substitute for patients with tyrosinaemia.

Trial Locations (2)

L7 8XP

National Alkaptonuria Centre, Royal Liverpool University Hospital, Liverpool

B4 6NH

Birmingham Children's Hospital, Birmingham

All Listed Sponsors
lead

Vitaflo International, Ltd

INDUSTRY

NCT04196959 - Evaluation of TYR Sphere | Biotech Hunter | Biotech Hunter